These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27669236)

  • 1. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.
    Auguet T; Aragonès G; Berlanga A; Guiu-Jurado E; Martí A; Martínez S; Sabench F; Hernández M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    Aragonès G; Auguet T; Armengol S; Berlanga A; Guiu-Jurado E; Aguilar C; Martínez S; Sabench F; Porras JA; Ruiz MD; Hernández M; Sirvent JJ; Del Castillo D; Richart C
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
    Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease.
    Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Porras JA; Aragonès G; Sabench F; Hernandez M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
    Int J Mol Sci; 2014 Dec; 15(12):22173-87. PubMed ID: 25474087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A micro-RNA expression signature for human NAFLD progression.
    Guo Y; Xiong Y; Sheng Q; Zhao S; Wattacheril J; Flynn CR
    J Gastroenterol; 2016 Oct; 51(10):1022-30. PubMed ID: 26874844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population.
    Pillai SS; Lakhani HV; Zehra M; Wang J; Dilip A; Puri N; O'Hanlon K; Sodhi K
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepcidin in morbidly obese women with non-alcoholic fatty liver disease.
    Auguet T; Aragonès G; Berlanga A; Martínez S; Sabench F; Binetti J; Aguilar C; Porras JA; Molina A; Del Castillo D; Richart C
    PLoS One; 2017; 12(10):e0187065. PubMed ID: 29065180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
    Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
    World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease.
    Okushin K; Tsutsumi T; Enooku K; Fujinaga H; Kado A; Shibahara J; Fukayama M; Moriya K; Yotsuyanagi H; Koike K
    J Gastroenterol; 2016 Aug; 51(8):808-18. PubMed ID: 26601667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    Aragonès G; Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Armengol S; Sabench F; Ras R; Hernandez M; Aguilar C; Colom J; Sirvent JJ; Del Castillo D; Richart C
    PLoS One; 2016; 11(4):e0154601. PubMed ID: 27123846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic miR-33a/miR-144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects.
    Vega-Badillo J; Gutiérrez-Vidal R; Hernández-Pérez HA; Villamil-Ramírez H; León-Mimila P; Sánchez-Muñoz F; Morán-Ramos S; Larrieta-Carrasco E; Fernández-Silva I; Méndez-Sánchez N; Tovar AR; Campos-Pérez F; Villarreal-Molina T; Hernández-Pando R; Aguilar-Salinas CA; Canizales-Quinteros S
    Liver Int; 2016 Sep; 36(9):1383-91. PubMed ID: 26945479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.
    Okamoto K; Koda M; Okamoto T; Onoyama T; Miyoshi K; Kishina M; Kato J; Tokunaga S; Sugihara TA; Hara Y; Hino K; Murawaki Y
    PLoS One; 2016; 11(5):e0154676. PubMed ID: 27135827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity.
    Li YJ; Baumert BO; Stratakis N; Goodrich JA; Wu HT; He JX; Zhao YQ; Aung MT; Wang HX; Eckel SP; Walker DI; Valvi D; La Merrill MA; Ryder JR; Inge TH; Jenkins T; Sisley S; Kohli R; Xanthakos SA; Baccarelli AA; McConnell R; Conti DV; Chatzi L
    World J Gastroenterol; 2024 Jan; 30(4):332-345. PubMed ID: 38313232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.
    Latorre J; Moreno-Navarrete JM; Mercader JM; Sabater M; Rovira Ò; Gironès J; Ricart W; Fernández-Real JM; Ortega FJ
    Int J Obes (Lond); 2017 Apr; 41(4):620-630. PubMed ID: 28119530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD.
    Estep JM; Goodman Z; Sharma H; Younossi E; Elarainy H; Baranova A; Younossi Z
    Liver Int; 2015 Apr; 35(4):1367-72. PubMed ID: 24684403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Tanshinone IIA on the modulation of miR‑33a and the SREBP‑2/Pcsk9 signaling pathway in hyperlipidemic rats.
    Jia L; Song N; Yang G; Ma Y; Li X; Lu R; Cao H; Zhang N; Zhu M; Wang J; Leng X; Cao Y; Du Y; Xu Y
    Mol Med Rep; 2016 Jun; 13(6):4627-35. PubMed ID: 27082100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects.
    Ma DW; Arendt BM; Hillyer LM; Fung SK; McGilvray I; Guindi M; Allard JP
    Nutr Diabetes; 2016 Jul; 6(7):e220. PubMed ID: 27428872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids.
    Arendt BM; Comelli EM; Ma DW; Lou W; Teterina A; Kim T; Fung SK; Wong DK; McGilvray I; Fischer SE; Allard JP
    Hepatology; 2015 May; 61(5):1565-78. PubMed ID: 25581263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease.
    Braza-Boïls A; Marí-Alexandre J; Molina P; Arnau MA; Barceló-Molina M; Domingo D; Girbes J; Giner J; Martínez-Dolz L; Zorio E
    Liver Int; 2016 Aug; 36(8):1221-9. PubMed ID: 26901384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
    Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.